Skip to main content

Table 1 Clinical characteristics of participating patients at baseline

From: Effects of combining two techniques of non-invasive brain stimulation in subacute stroke patients: a pilot study

 

Active

Sham

P-value

Number of patients

5

5

 

Age*

58.8 (5.9)

59.2 (17.5)

0.97

Time since stroke (days)*

35.2 (21.7)

47.4 (25.0)

0.43

Gender - male:female

1:4

1:4

1.00a

Type of stroke

 - Ischemic stroke

4

4

1.00 a

 - Hemorrhagic stroke

1

1

 

Side of brain lesion

 - Left

3

3

1.00 a

 - Right

2

2

 

Education

 - Primary school

2

2

0.34b

 - Secondary school

2

0

 

 - Vocational certificate

1

2

 

 - Higher education

0

1

 

MRC-UE*

2.80 (1.09)

2.20 (2.05)

0.58

MRC-LE*

1.20 (1.30)

2.00 (1.87)

0.45

BS-ARM*

3.60 (0.89)

3.20 (1.09)

0.54

BS-HAND*

2.80 (1.30)

3.00 (1.00)

0.79

FMA-UE*

23.40 (13.47)

21.40 (12.68)

0.81

WMFT-FAS*

28.40 (11.72)

28.20 (15.01)

0.98

WMFT-TIME*

87.69 (20.71)

89.51 (29.76)

0.91

  1. MRC-UE Medical Research Council scale of upper extremity, MRC-LE Medical Research Council scale of lower extremity, FMA-UE Fugl-Meyer upper extremity motor score, WMFT-FAS Wolf motor function test - Functional ability, WMFT-TIME Wolf motor function test-Performance time
  2. aP-value by Fisher’s Exact test
  3. bP-value by Chi-squared test
  4. *Mean (standard deviation); p-value by Independence t-test